A versatile tool for conditional gene expression and knockdown

Nature Methods

Volumn 3, Issue 2, 2006, Pages 109-116

  Szulc, Jolanta ^a   Wiznerowicz, Maciej ^a,b   Sauvain, Marc Olivier ^a,b   Trono, Didier ^a,b   Aebischer, Patrick ^a  

^a EPFL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; DOXYCYCLINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LENTIVIRUS VECTOR; RNA POLYMERASE II; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CELL LINE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FEMALE; FERTILIZATION; GENE EXPRESSION SYSTEM; GENE SEQUENCE; GENETIC CODE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; KNOCKOUT GENE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OOCYTE; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; RAT; TRANSGENE; TRANSGENIC MOUSE; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; BACTERIAL PROTEINS; BRAIN; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; DNA POLYMERASE II; DNA POLYMERASE III; DOXYCYCLINE; FEMALE; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC ENGINEERING; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEINS; HUMANS; LENTIVIRUS; MALE; MICE; MICE, INBRED STRAINS; MICE, NUDE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; STEM CELLS; TRANSFECTION; TRANSGENES; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; LENTIVIRUS; MAMMALIA; MUS MUSCULUS;

EID: 31744445721     PISSN: 15487091     EISSN: 15491676     Source Type: Journal    
DOI: 10.1038/nmeth846     Document Type: Article

References (31)

1. Toniatti, C., Bujard, H., Cortese, R. & Ciliberto, G. Gene therapy progress and prospects: Transcription regulatory systems. Gene Ther. 11, 649-657 (2004).
2. Gossen, M. & Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551 (1992).
3. Gossen, M. et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769 (1995).
4. Urlinger, S. et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. USA 97, 7963-7968 (2000).
5. Rossi, F.M. et al. Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat. Genet. 20, 389-393 (1998).
6. Vogel, R., Amar, L., Thi, A.D., Saillour, P. & Mallet, J. A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain. Hum. Gene Ther. 15, 157-165 (2004).
7. Kafri, T., van Praag, H., Gage, F.H. & Verma, I.M. Lentiviral vectors: regulated gene expression. Mol. Ther. 1, 516-521 (2000).
8. Vigna, E. et al. Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol. Ther. 5, 252-261 (2002).
9. Wiznerowicz, M. & Trono, D. Harnessing HIV for therapy, basic research and biotechnology. Trends Biotechnol. 23, 42-47 (2005).
10. Hannon, G.J. & Rossi, J.J. Unlocking the potential of the human genome with RNA interference. Nature 431, 371-378 (2004).
11. Chen, Y. Stamatoyannopoulos, G. & Song, C.Z. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. 63, 4801-4804 (2003).
12. Ventura, A. et al. Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA 101, 10380-10385 (2004).
13. Gupta, S., Schoer, R.A., Egan, J.E., Hannon, G.J. & Mittal, V. Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 101, 1927-1932 (2004).
14. Stegmeier, F., Hu, G., Rickles, R.J., Hannon, G.J. & Elledge, S.J. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 102, 13212-13217 (2005).
15. Dickins, R.A. et al. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Genet. 37, 1289-1295 (2005).
16. Margolin, J.F. et al. Kruppel-associated boxes are potent transcriptional repression domains. Proc. Natl. Acad. Sci. USA 91, 4509-4513 (1994).
17. Deuschle, U., Meyer, W.K. & Thiesen, H.J. Tetracycline-reversible silencing of eukaryotic promoters. Mol. Cell. Biol. 15, 1907-1914 (1995).
18. Moosmann, P., Georgiev, O., Thiesen, H.J., Hagmann, M. & Schaffner, W. Silencing of RNA polymerases II and III-dependent transcription by the KRAB protein domain of KOX1, a Kruppel-type zinc finger factor. Biol. Chem. 378, 669-677 (1997).
19. Senatore, B. et al. A variety of RNA polymerases II and III-dependent promoter classes is repressed by factors containing the Kruppel-associated/finger preceding box of zinc finger proteins. Gene 234, 381-394 (1999).
20. Wiznerowicz, M. & Trono, D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77, 8957-8961 (2003).
21. Urrutia, R. KRAB-containing zinc-finger repressor proteins. Genome Biol. 4, 231 (2003).
22. Asante, E.A., Gowland, I., Linehan, J.M., Mahal, S.P. & Collinge, J. Expression pattern of a mini human PrP gene promoter in transgenic mice. Neurobiol. Dis. 10, 1-7 (2002).
23. Kordower, J.H. et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767-773 (2000).
24. Kirik, D., Georgievska, B. & Bjorklund, A. Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat. Neurosci. 7, 105-110 (2004).
25. Georgievska, B., Kirik, D. & Bjorklund, A. Aberrant sprouting and down regulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 177, 461-474 (2002).
26. Georgievska, B. et al. Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector. Hum. Gene Ther. 15, 934-944 (2004).
27. Bjorklund, A. et al. Towards a neuroprotective gene therapy for Parkinson's disease: Use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res. 886, 82-98 (2000).
28. Cantor, A.B. & Orkin, S.H. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 21, 3368-3376 (2002).
29. Zhang, P. et al. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc. Natl. Acad. Sci. USA 96, 8705-8710 (1999).
30. Lois, C., Hong, E.J., Pease, S., Brown, E.J. & Baltimore, D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868-872 (2002).
31. Pfeifer, A., Ikawa, M. Dayn, Y. & Verma, I.M. Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc. Natl. Acad. Sci USA 99, 2140-2145 (2002).